There are two antibodies already on the market that target PCSK9 – Amgen’s Repatha (evolocumab) and Sanofi/Regeneron’s Repatha (alirocumab) – but these require subcutaneous injection every ...

Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of ...

Many people know diet and weight can increase your cholesterol levels but there are three drugs that can do the same ...

"I think you can put two, two and four together, and you'll probably come to the answer." "We don't [have any plans], you know, Code Orange is on the shelf, and I think it's there for a good ...

(NASDAQ: REGN) today announced that the European Commission (EC) has granted conditional marketing approval of Lynozyfic™ (linvoseltamab) to treat adults with relapsed and refractory (R/R) multiple ...

Knowing your cholesterol levels is important. Too low or too high can have implications for your health. If it is too low it can cause a condition called hypocholesterolemia or hypolipidemia. This ...

Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma Lynozyfic will provide a new option with convenient dosing and administration to patie ...

Moises Sandoval Mendoza, 41, was executed by lethal injection on Wednesday for the murder of 20-year-old Rachelle O’Neil Tolleson. Mendoza’s execution, witnessed by Tolleson’s mother and ...

Weight loss injections are a popular option for those hoping to shed pounds quickly and effectively. These medications alter appetite and metabolism to help support long-term weight loss — but ...

Moises Sandoval Mendoza, 41, was executed by lethal injection on Wednesday for the murder of 20-year-old Rachelle O’Neil Tolleson. Mendoza’s execution, witnessed by Tolleson’s mother and other family ...

The consensus among analysts is that 'Revenues- Praluent (alirocumab)- US' will reach $57.71 million. The estimate points to a change of -17.6% from the year-ago quarter. Analysts' assessment ...